VA Faces Pressure to Formally Rescind Controversial Disability Rating Rule

The Department of Veterans Affairs (VA) is currently embroiled in a significant regulatory and legal dispute following the publication of a rule on February 17, 2026, that fundamentally alters how disability ratings are calculated. The regulation requires medical examiners to consider the effectiveness of treatments or medications when determining a veteran's compensation rating. This shift means that if a veteran’s condition improves due to successful medical intervention, their disability rating—and subsequent financial compensation—could be reduced. While VA Secretary Doug Collins has verbally committed to a policy of non-enforcement, the refusal to formally rescind the rule has sparked a firestorm among veterans' advocacy groups and members of Congress who view the 'on-the-books' status as a persistent threat to veteran welfare.

At the heart of the VA’s defense is the 2025 court ruling in Ingram v. Collins. VA officials argue that the new regulation is a necessary administrative response to this precedent, which potentially forces the department to reconsider 350,000 claims decisions. The department maintains that the rule merely formalizes a practice dating back to 1958, intended to ensure that compensation reflects the 'actual level of impairment' experienced in daily life. From a fiscal perspective, the VA warns that without this rule, the department would face a massive surge in compensation expenditures for disability levels that veterans are not actually experiencing due to successful treatment. This highlights a growing tension in RegTech and administrative law: the balance between fiscal responsibility and the perceived 'earned' nature of veteran benefits.

“

The Department of Veterans Affairs (VA) is currently embroiled in a significant regulatory and legal dispute following the publication of a rule on February 17, 2026, that fundamentally alters how disability ratings are calculated.

However, the legal community and veterans' advocates, including the Disabled American Veterans (DAV), argue that the rule creates a perverse incentive for veterans to avoid necessary medical care. DAV National Commander Coleman Nee articulated this concern during a recent hearing, stating that no veteran should be penalized for taking the medication they need to survive. The controversy is further compounded by allegations that the VA sidestepped the standard regulatory process and public comment periods before publishing the rule. This procedural shortcut has led to more than 18,000 comments in the Federal Register, the vast majority of which are critical. For RegTech professionals, this case serves as a primary example of how administrative shortcuts can lead to massive public backlash and potential litigation regarding the Administrative Procedure Act (APA).